Skip to main content
Subscribe
  • Login
  • My Account
  • Logout
  • Register For Free
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HLTH 2024
    • Sponsored Content: Vital Signs Blog
  • Opinion
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • 40 Under 40
    • Best Places to Work in Healthcare
    • Healthcare Marketing Impact Awards
    • Innovators Awards
    • Diversity Leaders
    • Leading Women
    • Best in Business Awards
    • The 2030 Playbook Conference
    • Innovations in Patient Experience
    • Leading Women Conference & Awards Luncheon
    • Leadership Summit
    • Workforce Summit
    • Best Places to Work Awards Gala
    • Diversity Leaders Gala
    • - Looking Ahead to 2025
    • - Financial Growth
    • - Hospital of the Future
    • - Value Based Care
    • - Looking Ahead to 2026
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Skilled Nursing Facilities
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
    • Sponsored Content
MENU
Breadcrumb
  1. Home
  2. Technology
May 06, 2017 12:00 AM

Fewer pharma rep visits linked to lower market share for their drugs

Alex Kacik
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    Pharmaceutical companies have long sought to bolster market share by promoting specific medications to doctors during sales visits and events that may include gifts such as meals and free samples, a practice known as drug detailing. A growing number of academic medical centers have sought to curb that practice by restricting visits by drugmakers.

    The efforts seem to be paying off; physicians prescribed fewer drugs that were being promoted by sales reps when their hospital limited visits by sales reps, according to a new study.

    Between 2006 and 2012, the market share of detailed drugs prescribed by academic medical centers dropped 8.7% relative to the level prior to enacting the policy changes, according to the study published last week in JAMA. Prescriptions shifted away from detailed drugs largely toward generic ones, the study found. Prior to the policy changes, detailed drugs held an average of 19.3% of the market share.

    "There has long been concern that drug marketing to physicians might influence their prescribing, including—and maybe especially—for psychiatric drugs," said one of the study co-authors, Michael Schoenbaum, a senior adviser for mental health services, epidemiology and economics at the National Institute of Mental Health, which supported the study. According to the study, there is little research on the definitive implications of drug detailing—mostly because the formidable pharmaceutical industry prevents it from coming to light.

    The Takeaway

    Physicians prescribed fewer drugs that were being promoted by sales reps when academic medical centers implemented policies restricting visits by those salespeople.

    And that's not the only place drugmakers spend money. The pharmaceutical industry spent more than $24 billion on marketing directly to physicians in 2012 compared with $3 billion a year to consumers, according to a study published by the Pew Charitable Trusts. About $15 billion of that was face-to-face selling and around $6 billion was in free samples. As of 2012, the U.S. had about 72,000 pharmaceutical sales representatives; there were 916,000 licensed physicians.

    Providing free samples to healthcare professionals led to significant increases in new prescriptions for the sampled drugs, per the Pew study. While drug companies argue that the samples are especially important to patients who couldn't afford them otherwise, research shows that most are given to insured patients.

    The decline in promoted drug prescriptions was more drastic following the implementation of stricter policies, including bans on salespeople in patient care areas; requirements for salesperson registration and training; and penalties for salespeople and physicians for violating the policies.

    Researchers studied 19 centers that implemented the new policies, including 2,126 physicians who practiced in California, Illinois, Massachusetts, New York and Pennsylvania, compared with a control group of 24,593 physicians. They analyzed more than 16 million prescriptions of eight major drug classes: lipid-lowering drugs, gastroesophageal reflux disease drugs, anti-diabetic agents, anti-hypertensive drugs, sleep aids, attention deficit hyperactivity disorder drugs, antidepressant drugs and antipsychotic drugs.

    "Important next steps include assessing the economic impact of these policies and whether they affect patients' clinical outcomes," Schoenbaum said.

    Soaring drug prices have taken a significant chunk out of hospitals' bottom lines. Annual inpatient drug spending rose an average of 23.4% from 2013 to 2015, and 38.7% on a per admission basis, according to a 2016 study from America's biggest hospital lobbies.​

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    IU Health Methodist
    IU Health patient data compromised in cyberattack
    U.S. Food and Drug Administration (FDA)
    Upcoming FDA draft on pulse oximetry's racial bias draws questions
    Most Popular
    1
    'Legendary' Hemsley takes over at UnitedHealth amid rough seas
    2
    Big retail tried to disrupt healthcare—who is making a dent?
    3
    These are the regulations the AHA wants RFK Jr. to scrap
    4
    Downside risk, upside payment highlight new CMS innovation agenda
    5
    Medicaid cuts bill clears key House committee
    Sponsored Content
    Digital Health Intelligence Newsletter: Sign up to receive a twice-weekly (T, F) morning newsletter featuring the latest reporting on technologies, trends, players and money fueling the rapid changes in how healthcare is developed, paid for and delivered.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2025. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HLTH 2024
      • Sponsored Content: Vital Signs Blog
    • Opinion
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • 40 Under 40
        • Best Places to Work in Healthcare
        • Healthcare Marketing Impact Awards
        • Innovators Awards
        • Diversity Leaders
        • Leading Women
        • Best in Business Awards
      • Conferences
        • The 2030 Playbook Conference
        • Innovations in Patient Experience
        • Leading Women Conference & Awards Luncheon
        • Leadership Summit
        • Workforce Summit
      • Galas
        • Best Places to Work Awards Gala
        • Diversity Leaders Gala
      • Virtual Briefings
        • - Looking Ahead to 2025
        • - Financial Growth
        • - Hospital of the Future
        • - Value Based Care
        • - Looking Ahead to 2026
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Skilled Nursing Facilities
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing
      • Sponsored Content